BRIEF

on DBV TECHNOLOGIES (EPA:DBV)

DBV Technologies Appoints James Briggs as Chief Human Resources Officer

Stock price chart of DBV TECHNOLOGIES (EPA:DBV) showing fluctuations.

On July 22, 2025, DBV Technologies, a clinical-stage biopharmaceutical company, announced the appointment of James Briggs as Chief Human Resources Officer. He succeeds Caroline Daniere and will play a key role in the company's transition to potential commercialization. Briggs will report to Daniel Tassé, Chief Executive Officer, and will serve on the Executive Committee.

Briggs brings extensive experience, most recently serving as a partner at East Bay Human Capital, specializing in human capital strategy. He notably led the turnaround of MNG Health. With a master's degree in human relations and SPHR certification, his expertise will be invaluable to DBV as it strengthens its organizational foundation.

Daniel Tassé expressed his gratitude to Caroline Daniere for her leadership and talent identification. Briggs is expected to continue this remarkable work to support DBV's mission: to provide innovative treatments to patients.

R. E.

Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all DBV TECHNOLOGIES news